Multiple COVID-19 Vaccines Make Their Way Toward Approval

By Ben Kieffer,

Rick Brewer, Matthew Alvarez

Published December 1, 2020 at 4:29 PM CST

FILE - In this March 16, 2020, file photo, pharmacist Michael Witte holds a tray with a syringe containing a shot that will be used in the first clinical trial of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. An influential scientific panel on Tuesday, Dec. 1, is set to tackle one of the most pressing questions in the U.S. coronavirus epidemic: When the first doses of COVID-19 vaccine become available, who should be at the front of the line for shots? (AP Photo/Ted S. Warren, File)

On this edition of River to River, host Ben Kieffer speaks with Dr. Stanley Perlman, a recognized world authority on coronaviruses, about the news of a vaccine arriving at a particularly grim moment in our health crisis, and how drugmakers Pfizer and Moderna have applied to the Food and Drug Administration to authorize their COVID-19 vaccines for emergency use.

Guest:

· Dr. Stanley Perlman, immunologist, microbiologist, University of Iowa Hospitals & Clinics

Tags